Covid19 Impact on Head Trauma Market : Global Trends, Analysis and Forecast

Market Highlights

Over the last decade, the number of hospitals has increased to a great extent, which has influenced the growth of the market positively. Moreover, increasing demand for better treatment and changing reimbursement policies have fueled the market growth.

According to the National Safety Council reports, head trauma caused estimated 4.6 million accident related injuries and 40,200 deaths in 2016 worldwide. Moreover, average car accident data from 2005-2015, it is estimated that 5,808,272 car accidents occur every year in the U.S.

Increasing prevalence of neurological/brain disorder like epilepsy, rising need for better treatment, increasing investment in biotechnology and pharmaceutical industries for R&D, and availability of funds drive the growth of the market. Furthermore, increasing government support for research & development, changing lifestyle, and rapid development in technology are likely to fuel the market growth during the forecast period. On the other hand, higher cost of the treatment procedure may slow the market growth during the review period.

The Global Head Trauma Market is expected to grow at a CAGR of ~8.3% during the forecast period 2017-2023.

Regional Analysis

The Americas dominate the global head trauma market owing to the presence of huge patient population, high health care spending, and increasing government support for research & development. Moreover presence of major market players may boost the market growth during the forecast period.      

Europe holds the second largest share of the global market. The increasing focus of various government agencies on treating various brain disorders or brain injuries such as epilepsy, and depression are likely to have a positive impact on the growth of the market. The growing public awareness may boost the adoption of these devices in the European market.

Asia Pacific is the fastest growing head trauma market across the globe. Japan holds the major share of the regional market due to availability of technology and huge healthcare spending. Rapidly developing economy, increasing healthcare expenditure, and government initiatives for research & development will drive the market in China and India over the assessment period.       

The Middle East and Africa hold the least share of the global market due to limited availability of medical facilities. The UAE, Saudi Arabia, and Kuwait are expected to drive the Middle East & African market. Whereas, the African region is expected to witness a moderate growth.  

Segmentation

The global head trauma market is segmented on the basis of types, diagnosis, treatment, and end user. On the basis of the type, it is segmented into hematoma, and hemorrhage. On the basis of the diagnosis, it is segmented into physical examination, blood test, brain scans, and others. The brain scan is further segmented into computerized tomography (CT) scan, magnetic resonance imaging (MRI) and electroencephalography (EEG). Based on the treatment it is segmented into medical treatment, anti-seizure drugs, surgery, and others. On the basis of the end user, it is segmented into hospitals & clinics, research laboratories, and others.

Key Players

Some of key the players in the market are Fujifilm Holdings (Japan), GE Healthcare (U.S.), Siemens Healthcare(U.S.), Philips Healthcare (U.S.), Shimadzu Corporation (Japan), Toshiba Medical Systems Corporation (Japan), Carestream Health (U.S.), Nihon Kohden Corporation (Japan), Electrical Geodesics Inc. (U.S.), Masimo Corporation (U.S.), Hologic (U.S.), Esaote (Italy), and others.

Browse Full Report @ https://www.marketresearchfuture.com/reports/head-trauma-market-5225 .

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com 

Head Trauma market size Global Insights, Forecast 2020- 2023 - MRFR

Head Trauma Market – Overview

Rise in the number of trauma cases globally especially those of head trauma have prompted an increase in the demand for treatment. Market reports connected with the healthcare industry have been made accessible by Market Research Future who publishes reports on other sectors that have been recently put out along with a report on this industry. The market growth is foreseen to grow with a CAGR of 8.3% over the forecast period. The progress of the market is expected to benefit from the development of new technologies in the upcoming forecast period.

Segmental Analysis

The segmentation of the head trauma market size is segmented on the basis of types, diagnosis, treatment and end users. By types, the market is segmented into haemorrhage and hematoma. By diagnosis, the market is segmented into brain scans, physical examination, and CT scan. By treatment, the market segmentation comprises of anti-seizure drugs, medical treatment, and surgery. By end users, the market is segmented into research institutes and hospitals & clinics.

Detailed Regional Analysis 

The Americas region dominates the market due to the incidence of well-developed technology, growing patient population share with brain disorder, increasing health care spending, and budding government support for research & development. Additionally, intensified R&D activities and the focus of major companies are fuelling the market growth in this region. The European region has the next spot in the market due to the government support for research & development and accessibility of funds for research. This is projected to continue to drive the European market over the forecasted period. The Asia Pacific is showing the fastest growth due to the swiftly evolving healthcare technologies and high healthcare expenditure. Furthermore, the rising patient population in nations like India and South Korea are likely to fortify the market in the forecast period further. Conversely, the Middle East & Africa region controls the least stake in the market due to less accessibility of funds, inadequate medical facilities, and volatile political conditions in the African continent.

Segmentation

The global head trauma market is segmented on the basis of types, diagnosis, treatment, and end user. On the basis of the type, it is segmented into hematoma, and hemorrhage. On the basis of the diagnosis, it is segmented into physical examination, blood test, brain scans, and others. The brain scan is further segmented into computerized tomography (CT) scan, magnetic resonance imaging (MRI) and electroencephalography (EEG). Based on the treatment it is segmented into medical treatment, anti-seizure drugs, surgery, and others. On the basis of the end user, it is segmented into hospitals & clinics, research laboratories, and others.

Key Players

Some of key the players in the market are Fujifilm Holdings (Japan), GE Healthcare (U.S.), Siemens Healthcare(U.S.), Philips Healthcare (U.S.), Shimadzu Corporation (Japan), Toshiba Medical Systems Corporation (Japan), Carestream Health (U.S.), Nihon Kohden Corporation (Japan), Electrical Geodesics Inc. (U.S.), Masimo Corporation (U.S.), Hologic (U.S.), Esaote (Italy), and others.

Browse Full Report @ https://www.marketresearchfuture.com/reports/head-trauma-market-5225 .

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com 

Head Trauma Market Booming With Size, Industry trends and Forecast to 2023

Head Trauma Market – Overview

Rise in the number of trauma cases globally especially those of head trauma have prompted an increase in the demand for treatment. Market reports connected with the healthcare industry have been made accessible by Market Research Future who publishes reports on other sectors that have been recently put out along with a report on this industry. The Head Trauma Market growth is foreseen to grow with a CAGR of 8.3% over the forecast period. The progress of the market is expected to benefit from the development of new technologies in the upcoming forecast period.

Segmental Analysis

The segmentation of the market is segmented on the basis of types, diagnosis, treatment and end users. By types, the market is segmented into haemorrhage and hematoma. By diagnosis, the market is segmented into brain scans, physical examination, and CT scan. By treatment, the market segmentation comprises of anti-seizure drugs, medical treatment, and surgery. By end users, the market is segmented into research institutes and hospitals & clinics.

Detailed Regional Analysis 

The Americas region dominates the market due to the incidence of well-developed technology, growing patient population share with brain disorder, increasing health care spending, and budding government support for research & development. Additionally, intensified R&D activities and the focus of major companies are fuelling the market growth in this region. The European region has the next spot in the market due to the government support for research & development and accessibility of funds for research. This is projected to continue to drive the European market over the forecasted period. The Asia Pacific is showing the fastest growth due to the swiftly evolving healthcare technologies and high healthcare expenditure. Furthermore, the rising patient population in nations like India and South Korea are likely to fortify the market in the forecast period further. Conversely, the Middle East & Africa region controls the least stake in the market due to less accessibility of funds, inadequate medical facilities, and volatile political conditions in the African continent.

Competitive Analysis

The inventions in the products and services are the major factor in growing the market's yield and affecting the trends that are capturing attention in the market. The key success factors and players’ tendencies are regularly improving by the strategies being used by market contenders. The external factors are encouraging the market development which is dependent on the practices and the strategic roadmaps that are developed by market competitors. The significant contenders functioning in the market are GE Healthcare (U.S.), Fujifilm Holdings (Japan), Siemens Healthcare (U.S.), Shimadzu Corporation (Japan), Philips Healthcare (U.S.), Nihon Kohden Corporation (Japan), Toshiba Medical Systems Corporation (Japan), Electrical Geodesics Inc. (U.S.), Carestream Health (U.S.), Masimo Corporation (U.S.), Hologic (U.S.), Esaote (Italy), and others.

Industry Updates:

Feb 2018 The first blood test to evaluate mild traumatic brain injury (mTBI) or concussion has been permitted to be marketed by the U.S. Food and Drug Administration. The FDA reviewed and authorized for marketing the Banyan Brain Trauma Indicator in less than six months as a portion of its Breakthrough Devices Program.

Read More @ https://www.marketresearchfuture.com/reports/head-trauma-market-5225